Evaluation of RFID Localization System for Marking and Retrieving Breast Lesions

Withdrawn before enrolling

Conditions studied: Non-palpable Breast Lesions

In brief

The goal of this investigation is to obtain clinical data to show the Health Beacons Radiofrequency Identification (RFID) Localization System is safe and performs as intended as a localization device for marking and retrieving a non-palpable surgical target from the breast.

Key facts

Study ID

NCT01574664

Run by

Health Beacons

People needed

0

Starts

2012-09-01

Expected to finish

2017-06-01

Last updated by the study team

2020-05-21

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Have had stereotactic or ultrasound-guided biopsy with marker placement
• Have a lesion or biopsy marker that is visible under ultrasound
• Have surgical target < 6 cm from the skin when lying supine
• Have a discreet surgical target
• Have a lesion in which the center/focal area is defined
• Be at least 18 years of age or older

You may not qualify if…

• Have a palpable lesion that does not require localization
• Require more than one localization needle for localization of the surgical target
• Have undergone previous open surgical biopsy or lumpectomy in the operative breast
• Have an implant in the operative breast
• Have a cardiac pacemaker or defibrillator device

Where it is running

• Sharp Memorial Hospital — San Diego, California, United States
• Harbor-UCLA Medical Center — Torrance, California, United States
• Exempla Healthcare — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.